Delivery Order SPE2DX15D9329-SPE2DX20FG7Y7

Award Date 9/22/20

Potential Completion Date 10/14/20

Potential Value $125K

Federal Agency

Medical Supply Chain

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

325411 - Medicinal and Botanical Manufacturing

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is a firm-fixed-price delivery order with a potential value of $124,640.00. It is not associated with a set-aside program.

The contract requires DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical products to support military treatment facilities, including items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other supplies. This delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical that has a potential value of up to $5 million through December 2025, under which DMS Pharmaceutical Group provides pharmaceutical and medical products on a firm-fixed-price basis to fulfill the routine needs of military treatment centers supported by the Defense Logistics Agency worldwide.

Generated 3/24/24, 8:47 AM